Metabolic phenotyping reveals a reduction in the bioavailability of serotonin and kynurenine pathway metabolites in both the urine and serum of individuals living with Alzheimer’s disease. / Whiley, Luke; Chappell, Katie; D'Hondt, Ellie; Lewis, Matthew; Jimenez, Beatriz; Snowden, Stuart; Soininen, Hilkka ; Kloszewska, Iwona; Mecocci, Patrizia; Tsolaki, Magda; Vellas, Bruno; Swann, Jonathan; Hye, Abdul ; Lovestone, Simon ; Legido-Quigley, Cristina; Holmes, Elaine.

In: Alzheimer's Research and Therapy, Vol. 13, 20, 09.01.2021.

Research output: Contribution to journalArticlepeer-review

  • Luke Whiley
  • Katie Chappell
  • Ellie D'Hondt
  • Matthew Lewis
  • Beatriz Jimenez
  • Stuart Snowden
  • Hilkka Soininen
  • Iwona Kloszewska
  • Patrizia Mecocci
  • Magda Tsolaki
  • Bruno Vellas
  • Jonathan Swann
  • Abdul Hye
  • Simon Lovestone
  • Cristina Legido-Quigley
  • Elaine Holmes
Original languageEnglish
Article number20
JournalAlzheimer's Research and Therapy
Publication statusPublished - 9 Jan 2021
This open access research output is licenced under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.

ID: 41620392